3-[beta-D-Glc-(1->6)-beta-D-Glc-(1->6)-beta-D-Glc-yl]-1,2-dimyristoyl-sn-glycerol

Term ID

CHEBI:149784

Synonyms

(2S)-3-{[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl]oxy}propane-1,2-diyl ditetradecanoate
(2S)-3-{[beta-D-glucosyl-(1->6)-beta-D-glucosyl-(1->6)-beta-D-glucosyl]oxy}propane-1,2-diyl dimyristoylate
3-[beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Glcp-yl]-1,2-dimyristoyl-sn-glycerol
WH103

Definition

A glycosylglycerol derivative in which the glycosyl moiety of glycosyl-sn-glycerol is beta-D-glucosyl-(1->6)-beta-D-glucosyl-(1->6)-beta-D-glucosyl attached at O-3, with O-1 and O-2 both carrying myristoyl substituents. Synthetic C. difficile lipoteichoic acid (LTA) molecule consisting only of lipid + core region.

References

PMID:32191024

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycosylglycerol derivative

glycosylglycerol derivative Show first 5 Terms
has_functional_parent: 1,2-ditetradecanoyl-sn-glycerol

1,2-ditetradecanoyl-sn-glycerol Show first 5 Terms

Phenotype

Phenotype resulting from 3-[beta-D-Glc-(1->6)-beta-D-Glc-(1->6)-beta-D-Glc-yl]-1,2-dimyristoyl-sn-glycerol

Phenotype where environments contain 3-[beta-D-Glc-(1->6)-beta-D-Glc-(1->6)-beta-D-Glc-yl]-1,2-dimyristoyl-sn-glycerol

Phenotype modified by environments containing 3-[beta-D-Glc-(1->6)-beta-D-Glc-(1->6)-beta-D-Glc-yl]-1,2-dimyristoyl-sn-glycerol

Human Disease Model